225 related articles for article (PubMed ID: 33477996)
1. Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.
Biello F; Platini F; D'Avanzo F; Cattrini C; Mennitto A; Genestroni S; Martini V; Marzullo P; Aimaretti G; Gennari A
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477996
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.
De Leon DD; Bakker B; Wilson DM; Hintz RL; Rosenfeld RG
Biochem Biophys Res Commun; 1988 Apr; 152(1):398-405. PubMed ID: 2451917
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis.
Hawsawi Y; El-Gendy R; Twelves C; Speirs V; Beattie J
Biochim Biophys Acta; 2013 Dec; 1836(2):345-53. PubMed ID: 24189571
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis.
Meneses-Echávez JF; Jiménez EG; Río-Valle JS; Correa-Bautista JE; Izquierdo M; Ramírez-Vélez R
BMC Cancer; 2016 Aug; 16(1):682. PubMed ID: 27562357
[TBL] [Abstract][Full Text] [Related]
8. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
9. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
10. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.
Hamelers IH; Steenbergh PH
Endocr Relat Cancer; 2003 Jun; 10(2):331-45. PubMed ID: 12790794
[TBL] [Abstract][Full Text] [Related]
11. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.
Christodoulatos GS; Spyrou N; Kadillari J; Psallida S; Dalamaga M
Curr Obes Rep; 2019 Dec; 8(4):413-433. PubMed ID: 31637624
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
13. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
14. Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer.
Peña-Cano MI; Saucedo R; Morales-Avila E; Valencia J; Zavala-Moha JA; López A
Gynecol Obstet Invest; 2019; 84(4):369-377. PubMed ID: 30650411
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors and breast cancer.
Lee AV; Yee D
Biomed Pharmacother; 1995; 49(9):415-21. PubMed ID: 8746077
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
Bieghs L; Johnsen HE; Maes K; Menu E; Van Valckenborgh E; Overgaard MT; Nyegaard M; Conover CA; Vanderkerken K; De Bruyne E
Oncotarget; 2016 Jul; 7(30):48732-48752. PubMed ID: 27129151
[TBL] [Abstract][Full Text] [Related]
17. Insulin and IGFs in obesity-related breast cancer.
Belardi V; Gallagher EJ; Novosyadlyy R; LeRoith D
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):277-89. PubMed ID: 24154546
[TBL] [Abstract][Full Text] [Related]
18. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract][Full Text] [Related]
19. Targeting insulin-like growth factor in breast cancer therapeutics.
Karamouzis MV; Papavassiliou AG
Crit Rev Oncol Hematol; 2012 Oct; 84(1):8-17. PubMed ID: 22424863
[TBL] [Abstract][Full Text] [Related]
20. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
Simone V; D'Avenia M; Argentiero A; Felici C; Rizzo FM; De Pergola G; Silvestris F
Oncologist; 2016 Apr; 21(4):404-17. PubMed ID: 26865587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
